Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 10, 2013, Pages 3901-3906

  Wang, Eric ^a   Kawaoka, Shinpei ^a   Yu, Ming ^b   Shi, Junwei ^a,c   Ni, Ting ^d   Yang, Wenjing ^d   Zhu, Jun ^d   Roeder, Robert G ^b   Vakoc, Christopher R ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cancer; Epigenetics

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; RING FINGER PROTEIN; RING FINGER PROTEIN 20; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HISTONE METHYLATION; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; TRANSCRIPTION ELONGATION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; GENE REARRANGEMENT; HISTONES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENES; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES;

EID: 84874638746     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1301045110     Document Type: Article

References (50)

1. Krivtsov AV, Armstrong SA (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7(11):823-833.
2. Radtke I, et al. (2009) Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci USA 106(31):12944-12949.
3. Shilatifard A (2012) The COMPASS family of histone H3K4 methylases: Mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem 81:65-95.
4. Milne TA, et al. (2010) Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis. Mol Cell 38(6):853-863.
5. Yokoyama A, et al. (2005) The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123(2):207-218.
6. Ayton PM, Chen EH, Cleary ML (2004) Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol Cell Biol 24(23):10470-10478.
7. Lin C, et al. (2010) AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37(3):429-437.
8. Bitoun E, Oliver PL, Davies KE (2007) The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 16(1):92-106.
9. Okada Y, et al. (2005) hDOT1L links histone methylation to leukemogenesis. Cell 121(2):167-178.
10. Tan J, et al. (2011) CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell 20(5):563-575.
11. Bernt KM, et al. (2011) MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20(1):66-78.
12. Jo SY, Granowicz EM, Maillard I, Thomas D, Hess JL (2011) Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. Blood 117(18):4759-4768.
13. Daigle SR, et al. (2011) Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20(1):53-65.
14. Grembecka J, et al. (2012) Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol 8(3):277-284.
15. Hwang WW, et al. (2003) A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. Mol Cell 11(1):261-266.
16. Wood A, et al. (2003) Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter. Mol Cell 11(1):267-274.
17. Kim J, Hake SB, Roeder RG (2005) The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions. Mol Cell 20(5):759-770.
18. Zhu B, et al. (2005) Monoubiquitination of human histone H2B: The factors involved and their roles in HOX gene regulation. Mol Cell 20(4):601-611.
19. Wood A, Schneider J, Dover J, Johnston M, Shilatifard A (2003) The Paf1 complex is essential for histone monoubiquitination by the Rad6-Bre1 complex, which signals for histone methylation by COMPASS and Dot1p. J Biol Chem 278(37):34739-34742.
20. Xiao T, et al. (2005) Histone H2B ubiquitylation is associated with elongating RNA polymerase II. Mol Cell Biol 25(2):637-651.
21. Kim J, et al. (2009) RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 137(3):459-471.
22. Pavri R, et al. (2006) Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 125(4):703-717.
23. Moyal L, et al. (2011) Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol Cell 41(5):529-542.
24. Nakamura K, et al. (2011) Regulation of homologous recombination by RNF20- dependent H2B ubiquitination. Mol Cell 41(5):515-528.
25. McGinty RK, Kim J, Chatterjee C, Roeder RG, Muir TW (2008) Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation. Nature 453(7196):812-816.
26. Shilatifard A (2008) Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr Opin Cell Biol 20(3):341-348.
27. Shema E, et al. (2008) The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes Dev 22(19):2664-2676.
28. Vethantham V, et al. (2012) Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 trimethylation during myogenic differentiation. Mol Cell Biol 32(6):1044-1055.
29. Chernikova SB, et al. (2012) Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability. Cancer Res 72(8):2111-2119.
30. Weake VM, Workman JL (2008) Histone ubiquitination: Triggering gene activity. Mol Cell 29(6):653-663.
31. Zuber J, et al. (2009) Mouse models of human AML accurately predict chemotherapy response. Genes Dev 23(7):877-889.
32. McJunkin K, et al. (2011) Reversible suppression of an essential gene in adult mice using transgenic RNA interference. Proc Natl Acad Sci USA 108(17):7113-7118.
33. Zuber J, et al. (2011) Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat Biotechnol 29(1):79-83.
34. Shi J, et al. (2012) The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia. Oncogene, 10.1038/onc.2012.110.
35. Subramanian A, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
36. Somervaille TC, et al. (2009) Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4(2):129-140.
37. Zuber J, et al. (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478(7370):524-528.
38. Jääskeläinen T, et al. (2012) Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth. Mol Cell Endocrinol 350(1):87-98.
39. Jung I, et al. (2012) H2B monoubiquitylation is a 5′-enriched active transcription mark and correlates with exon-intron structure in human cells. Genome Res 22(6): 1026-1035.
40. Steger DJ, et al. (2008) DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol 28(8): 2825-2839.
41. Muntean AG, et al. (2010) The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell 17(6):609-621.
42. Luo J, Solimini NL, Elledge SJ (2009) Principles of cancer therapy: Oncogene and non-oncogene addiction. Cell 136(5):823-837.
43. Bernstein BE, et al. (2005) Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2):169-181.
44. Ferraiuolo MA, et al. (2010) The three-dimensional architecture of Hox cluster silencing. Nucleic Acids Res 38(21):7472-7484.
45. Rinn JL, et al. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129(7):1311-1323.
46. Ito T, et al. (2010) Identification of a primary target of thalidomide teratogenicity. Science 327(5971):1345-1350.
47. Vassilev LT, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303(5659):844-848.
48. Armour CD, et al. (2009) Digital transcriptome profiling using selective hexamer priming for cDNA synthesis. Nat Methods 6(9):647-649.
49. Saldanha AJ (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20(17):3246-3248.
50. Yu M, et al. (2012) Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell 45(3):330-343.